Impact of Time to Treatment on Myocardial Reperfusion and Infarct Size With Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction (from the EMERALD Trial)

American Journal of Cardiology

Volumn 99, Issue 12, 2007, Pages 1680-1686

  Brodie, Bruce R ^a   Webb, John ^d   Cox, David A ^b   Qureshi, Mansoor ^e   Kalynych, Anna ^g   Turco, Mark ^h   Schultheiss, Heinz P ⁱ   Dulas, Daniel ^f   Rutherford, Barry ^j   Antoniucci, David ^k   Stuckey, Tom ^a   Krucoff, Mitch ^c   Gibbons, Raymond ^l   Lansky, Alexandra ^m   Na, Yingbo ^m   Mehran, Roxana ^m   Stone, Gregg W ^m  

^a LeBauer Cardiovascular Research Foundation   (United States)

^b Mid Carolina Cardiology   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d ST PAUL S HOSPITAL   (Canada)

^e ST JOSEPH MERCY HOSPITAL   (United States)

^f Mercy Hosp   (United States)

^g Cardiology of Georgia   (United States)

^h WASHINGTON ADVENTIST HOSPITAL   (United States)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j ST LUKE S HOSPITAL   (United States)

^k Policlinico di Careggi   (Italy)

^l MAYO CLINIC   (United States)

^m CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GUIDE WIRE; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; STENT; TIME; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 34249872704     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.01.047     Document Type: Article

References (26)

1. Berger P.B., Ellis S.G., Holmes D.R., Granger C.B., Criger D.A., Betriu A., Topol E.J., and Califf R.M. Relationship between delay in performing direct coronary angioplasty and early clinical outcomes in patients with acute myocardial infarction: results from the GUSTO-IIb trial. Circulation 100 (1999) 14-20
2. Brodie B.R., Stuckey T.D., Wall T.C., Kissling G., Hansen C.J., Muncy D.B., Weintraub R.A., and Kelly T.A. Importance of time to reperfusion for 30 day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 32 (1998) 1312-1319
3. Cannon C.P., Gibson C.M., Lambrew C.T., Shoultz D.A., Levy D., French W.J., Gore J.M., Weaver W.D., Rogers W.J., and Tiefenbrunn A.J. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000) 2941-2947
4. Brodie B.R., Stone G.W., Morice M.C., Cox D.A., Garcia E., Mattos L.A., Boura J., O'Neill W.W., Stuckey T.D., Milks S., Lansky A.J., Grines C.L., and Stent Primary Angioplasty in Myocardial Infarction Study Group. Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction: results from the Stent Primary Angioplasty in Myocardial Infarction Trial. Am J Cardiol 88 (2001) 1085-1090
5. Antoniucci D., Valenti R., Migliorini A., Moschi G., Trapani M., Buonamici P., Cerisano G., Bolognese L., and Santoro G.M. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 89 (2002) 1248-1252
6. De Luca G., Suryapranata H., Zijlstra F., van't Hof A.W., Hoorntje J.C., Gosselink A.T., Dambrink J.H., de Boer M.J., and ZWOLLE Myocardial Infarction Study Group. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 42 (2003) 991-997
7. Brodie B.R., Stone G.W., Cox D.A., Stuckey T.D., Turco M., Tcheng J.E., Berger P., Mehran R., McLaughlin M., Costantini C., Lansky A.J., and Grines C.L. Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC Trial. Am Heart J 151 (2006) 1231-1238
8. O'Keefe J.H., Grines C.L., DeWood M.A., Bateman T.M., Christian T.F., and Gibbons R.J. Factors influencing myocardial salvage with primary angioplasty. J Nucl Cardiol 2 (1995) 35-41
9. Milavetz J.J., Giebel D.W., Christian T.F., Schwartz R.S., Holmes D.R., and Gibbons R.J. Time to therapy and salvage in myocardial infarction. J Am Coll Cardiol 31 (1998) 1246-1251
10. Schomig A., Ndrepepa G., Mehilli J., Schwaiger M., Schuhlen H., Nekolla S., Pache J., Martinoff S., Bollwein H., and Kastrati A. Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation 108 (2003) 1084-1088
11. Schomig A., Mehilli J., Antoniucci D., Ndrepepa G., Markwardt C., Di Pede F., Nekolla S.G., Schlotterbeck K., Schuhlen H., Pache J., et al., Beyond 12 hours Reperfusion AlternatiVe Evaluation (BRAVE-2) Trial Investigators. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 293 (2005) 2865-2872
12. Stone G.W., Webb J., Cox D.A., Brodie B.R., Qureshi M., Kalynych A., Turco M., Schultheiss H.P., Dulas D., Rutherford B.D., et al., Enhanced Myocardial Efficacy and Recovery by Aspiration of Liberated Debris (EMERALD) Investigators. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 293 (2005) 1063-1072
13. Christian T.F., Schwartz R.S., and Gibbons R.J. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 86 (1992) 81-90
14. Gibbons R.J., Miller T.D., and Christian T.F. Infarct size measured by SPECT imaging with technetium-99m sestamibi-a measure of the efficacy of therapy in acute myocardial infarction. Circulation 101 (2000) 101-108
15. Stone G.W., Peterson M.A., Lansky A.J., Dangas G., Mehran R., and Leon M.B. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 39 (2002) 591-597
16. Costantini C.O., Stone G.W., Mehran R., Aymong E., Grines C.L., Cox D.A., Stuckey T., Turco M., Gersh B.J., Tcheng J.E., et al. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting with and without glycoprotein IIb/IIIa inhibition in acute myocardial infarction. J Am Coll Cardiol 44 (2004) 305-312
17. Rentrop K.P., Cohen M., Blanke H., and Phillips R.A. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5 (1985) 587-592
18. Krucoff M.W., Croll M.A., Pope J.E., Pieper K.S., Kanani P.M., Granger C.B., Veldkamp R.F., Wagner B.L., Sawchak S.T., and Califf R.M. Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. Am J Cardiol 71 (1993) 145-151
19. Roe M.T., Green C.L., Giugliano R.P., Gibson C.M., Baran K., Greenberg M., Palmeri S.T., Crater S., Trollinger K., Hannan K., Harrington R.A., Krucoff M.W., and INTEGRITI Investigators. Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol 43 (2004) 549-556
20. Schroder R., Wegscheider K., Schroder K., Dissmann R., and Meyer-Sabellek W. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. J Am Coll Cardiol 26 (1995) 1657-1664
21. Chareonthaitawee P., Gibbons R.J., Roberts R.S., Christian T.F., Burns R., and Yusuf S. The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. Heart 84 (2000) 142-148
22. Reimer K.A., Vander Heide R.S., and Richard V.J. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol 72 suppl (1993) 13G-21G
23. Clements I.P., Christian T.F., Higano S.T., Gibbons R.J., and Gersh B.J. Residual flow to the infarct zone as a determinant of infarct size after direct angioplasty. Circulation 88 (1993) 1527-1533
24. van't Hof A.W., Liem A., de Boer M.J., and Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 350 (1997) 615-619
25. Fu Y., Goodman S., Chang W.C., Van De Werf F., Granger C.B., and Armstrong P.W. Time to treatment influences the impact of ST-segment resolution on 1-year prognosis: insights from the ASSENT-II trial. Circulation 104 (2001) 2653-2659
26. Schroder K., Wegscheider K., Zeymer U., Tebbe U., and Schroder R. Extent of ST-segment deviation in a single electrocardiogram lead 90 minutes after thrombolysis as a predictor of medium term mortality in acute myocardial infarction. Lancet 358 (2001) 1479-1486